Given that BRD4 overexpression is associated with a worse prognosis of AML, dBET1 was tested in several AML cell lines representative of the different AML subtypes, against which it was shown to be strongly cytotoxic.125. The gene discussed is BRD4; the disease is acute myeloid leukemia.